Nothing
#' Abalone Data
#'
#' The Abalone data consist of data from 4177 abalones. The data consist of
#' measurements of the type (male, female and infant), the longest shell
#' measurement, the diameter, height and several weights (whole, shucked,
#' viscera and shell). The outcome is the number of rings. The age of the
#' abalone is the number of rings plus 1.5.
#'
#' The data are taken from the UCI database
#' (\url{https://archive.ics.uci.edu/ml/datasets/Abalone}).
#'
#'
#' @name abalone
#' @docType data
#' @return \item{abalone}{a data frame with 4177 rows and 9 columns}
#' @keywords datasets
#' @examples
#'
#' data(abalone)
#'
NULL
#' Alzheimer's Disease CSF Data
#'
#' Washington University conducted a clinical study to determine if biological
#' measurements made from cerebrospinal fluid (CSF) can be used to diagnose or
#' predict Alzheimer's disease (Craig-Schapiro et al. 2011). These data are a
#' modified version of the values used for the publication.
#'
#' The R factor vector \code{diagnosis} contains the outcome data for 333 of
#' the subjects. The demographic and laboratory results are collected in the
#' data frame \code{predictors}.
#'
#' One important indicator of Alzheimer's disease is the genetic background of
#' a subject. In particular, what versions of the Apolipoprotein E gene
#' inherited from one's parents has an association with the disease. There are
#' three variants of the gene: E2, E3 and E4. Since a child inherits a version
#' of the gene from each parent, there are six possible combinations (e.g.
#' E2/E2, E2/E3, and so on). This data is contained in the predictor column
#' named \code{Genotype}.
#'
#'
#' @name AlzheimerDisease
#' @aliases diagnosis predictors
#' @docType data
#' @return \item{diagnosis}{labels for the patients, either "Impaired" or
#' "Control". } \item{predictors}{predictors for demographic data (eg. age,
#' gender), genotype and assay results.}
#' @source Craig-Schapiro, R., Kuhn, M., Xiong, C., Pickering, E. H., Liu, J.,
#' Misko, T. P., Perrin, R. J., et al. (2011). Multiplexed Immunoassay Panel
#' Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and
#' Prognosis. PLoS ONE, 6(4), e18850.
#' @keywords datasets
#' @examples
#'
#' data(AlzheimerDisease)
#'
NULL
#' Chemical Manufacturing Process Data
#'
#' This data set contains information about a chemical manufacturing process,
#' in which the goal is to understand the relationship between the process and
#' the resulting final product yield. Raw material in this process is put
#' through a sequence of 27 steps to generate the final pharmaceutical product.
#' The starting material is generated from a biological unit and has a range of
#' quality and characteristics. The objective in this project was to develop a
#' model to predict percent yield of the manufacturing process. The data set
#' consisted of 177 samples of biological material for which 57 characteristics
#' were measured. Of the 57 characteristics, there were 12 measurements of the
#' biological starting material, and 45 measurements of the manufacturing
#' process. The process variables included measurements such as temperature,
#' drying time, washing time, and concentrations of by--products at various
#' steps. Some of the process measurements can be controlled, while others are
#' observed. Predictors are continuous, count, categorical; some are
#' correlated, and some contain missing values. Samples are not independent
#' because sets of samples come from the same batch of biological starting
#' material.
#'
#'
#' @name ChemicalManufacturingProcess
#' @docType data
#' @return \code{ChemicalManufacturingProcess}: a data frame with columns for
#' the outcome (\code{Yield}) and the predictors (\code{BiologicalMaterial01}
#' though \code{BiologicalMaterial12} and \code{ManufacturingProcess01} though
#' \code{ManufacturingProcess45}
#' @keywords datasets
#' @examples
#'
#' data(ChemicalManufacturingProcess)
#'
NULL
#' Compressive Strength of Concrete from Yeh (1998)
#'
#' Yeh (1998) describes a collection of data sets from different sources that
#' can be used for modeling the compressive strength of concrete formulations
#' as a functions of their ingredients and age.
#'
#' The data are from Yeh (1998) and taken from the UCI ML website
#' \url{https://archive.ics.uci.edu/ml/datasets/Concrete+Compressive+Strength}.
#'
#' There are 1030 data points from the UCI website, but the paper states that
#' approximately 1,000 samples were made, but only 727 were analyzed in the
#' source material. It is unclear which samples were excluded.
#'
#' @name concrete
#' @aliases concrete mixtures
#' @docType data
#' @return \item{concrete}{data frame of data with predictor columns
#' \code{Cement}, \code{BlastFurnaceSlag}, \code{FlyAsh}, \code{Water},
#' \code{Superplasticizer}, \code{CoarseAggregate}, \code{FineAggregate} and
#' \code{Age} with response column \code{CompressiveStrength}. These are the
#' amounts.} \item{mixtures}{The same data where all the ingredients have been
#' converted to proportions of the total amounts.}
#' @source Yeh, I. C. (1998). Modeling of strength of high-performance concrete
#' using artificial neural networks. \emph{Cement and Concrete Research},
#' 28(12), 1797-1808. Elsevier.
#' @keywords datasets
#' @examples
#'
#' if (require("caret")) {
#' data(concrete)
#'
#' library(caret)
#'
#' ### Split used in the book:
#' set.seed(975)
#' inTrain <- createDataPartition(mixtures$CompressiveStrength, p = 3/4)[[1]]
#' training <- mixtures[ inTrain,]
#' testing <- mixtures[-inTrain,]
#' }
#'
#'
NULL
#' Fuel Economy Data
#'
#' The \url{https://fueleconomy.gov} website, run by the U.S. Department of
#' Energy's Office of Energy Efficiency and Renewable Energy and the U.S.
#' Environmental Protection Agency, lists different estimates of fuel economy
#' for passenger cars and trucks. For each vehicle, various characteristics are
#' recorded such as the engine displacement or number of cylinders. Along with
#' these values, laboratory measurements are made for the city and highway
#' miles per gallon (MPG) of the car.
#'
#' Predictors extracted from the website include: \code{EngDispl},
#' \code{NumCyl}, \code{Transmission}, \code{AirAspirationMethod},
#' \code{NumGears}, \code{TransLockup}, \code{TransCreeperGear},
#' \code{DriveDesc}, \code{IntakeValvePerCyl}, \code{ExhaustValvesPerCyl},
#' \code{CarlineClassDesc}, \code{VarValveTiming} and \code{VarValveLift}. The
#' outcome used in the book is in column \code{FE} and is the unadjusted
#' highway data.
#'
#'
#' @name FuelEconomy
#' @aliases cars2010 cars2011 cars2012
#' @docType data
#' @return \item{cars2010}{data in cars from model year 2010. }
#' \item{cars2011}{cars introduced in 2011 that were not in the model year 2010
#' data.} \item{cars2012}{cars introduced in 2012 that were not in the model
#' year 2010 or 2011 data }
#' @keywords datasets
#' @examples
#'
#' data(FuelEconomy)
#'
#' library(lattice)
#'
#' ### Plot shown in the text:
#'
#' cars2010 <- cars2010[order(cars2010$EngDispl),]
#' cars2011 <- cars2011[order(cars2011$EngDispl),]
#'
#' cars2010a <- cars2010
#' cars2010a$Year <- "2010 Model Year"
#' cars2011a <- cars2011
#' cars2011a$Year <- "2011 Model Year"
#'
#' plotData <- rbind(cars2010a, cars2011a)
#'
#' plotTheme <- bookTheme(FALSE)
#' plotTheme$plot.symbol$col <- rgb(.2, .2, .2, .5)
#' plotTheme$plot.symbol$cex <- 0.7
#' trellis.par.set(plotTheme)
#'
#' xyplot(FE ~ EngDispl|Year, plotData,
#' xlab = "Engine Displacement",
#' ylab = "Fuel Efficiency (MPG)",
#' between = list(x = 1.2))
#'
#'
NULL
#' Hepatic Injury Data
#'
#' This data set was used to develop a model for predicting compounds'
#' probability of causing hepatic injury (i.e. liver damage). This data set
#' consisted of 281 unique compounds; 376 predictors were measured or computed
#' for each. The response was categorical (either "None", "Mild" or "Severe"
#' ),and was highly unbalanced.
#'
#' This kind of response often occurs in pharmaceutical data because companies
#' steer away from creating molecules that have undesirable characteristics.
#' Therefore, well-behaved molecules often greatly outnumber undesirable
#' molecules. The predictors consisted of measurements from 184 biological
#' screens and 192 chemical feature predictors. The biological predictors
#' represent activity for each screen and take values between 0 and 10 with a
#' mode of 4. The chemical feature predictors represent counts of important
#' sub-structures as well as measures of physical properties that are thought
#' to be associated with hepatic injury.
#'
#'
#' @name hepatic
#' @aliases bio chem injury
#' @docType data
#' @return \item{bio}{Biological screen results. } \item{chem}{Chemical
#' fingerprints for sub-structures.} \item{injury}{A factor vector of
#' outcomes.}
#' @keywords datasets
#' @examples
#'
#' data(hepatic)
#'
NULL
#' Internal Functions
#'
#' Internal functions
#'
#' @name apm-internal
#' @aliases lowerp upperp
#' @param \dots optional arguments to pass to internal functions
#' @author Max Kuhn
#' @keywords internal
NULL
#' HPC Job Scheduling Data
#'
#' These data consist of information on 4331 jobs in a high performance
#' computing environment. Seven attributes were recorded for each job along
#' with a discrete class describing the execution time.
#'
#' The predictors are: \code{Protocol} (the type of computation),
#' \code{Compounds} (the number of data points for each jobs),
#' \code{InputFields} (the number of characteristic being estimated),
#' \code{Iterations} (maximum number of iterations for the computations),
#' \code{NumPending} (the number of other jobs pending at the time of launch),
#' \code{Hour} (decimal hour of day for launch time) and \code{Day} (of launch
#' time).
#'
#' The classes are: \code{VF} (very fast), \code{F} (fast), \code{M} (moderate)
#' and \code{L} (long).
#'
#'
#' @name schedulingData
#' @docType data
#' @return \item{schedulingData}{a data frame with 4331 rows and 8 columns}
#' @keywords datasets
#' @examples
#'
#' data(schedulingData)
#'
#' library(caret)
#'
#' set.seed(1104)
#' inTrain <- createDataPartition(schedulingData$Class, p = .8, list = FALSE)
#'
#' schedulingData$NumPending <- schedulingData$NumPending + 1
#'
#' trainData <- schedulingData[ inTrain,]
#' testData <- schedulingData[-inTrain,]
#'
#' modForm <- as.formula(Class ~ Protocol + log10(Compounds) +
#' log10(InputFields)+ log10(Iterations) +
#' log10(NumPending) + Hour + Day)
#'
#'
#'
NULL
#' Logistic Regression Predictions for the Credit Data
#'
#' add some notes
#'
#'
#' @name logisticCreditPredictions
#' @docType data
#' @return A data frame with columns \item{Bad}{The predicted class probability
#' for bad credit. } \item{Good}{The predicted class probability for good
#' credit.} \item{pred}{The predicted class. } \item{obs}{The observed class }
#' @keywords datasets
#' @examples
#'
#' ## show code to make the predictions
#'
NULL
#' Permeability Data
#'
#' This pharmaceutical data set was used to develop a model for predicting
#' compounds' permeability. In short, permeability is the measure of a
#' molecule's ability to cross a membrane. The body, for example, has notable
#' membranes between the body and brain, known as the blood-brain barrier, and
#' between the gut and body in the intestines. These membranes help the body
#' guard critical regions from receiving undesirable or detrimental substances.
#' For an orally taken drug to be effective in the brain, it first must pass
#' through the intestinal wall and then must pass through the blood-brain
#' barrier in order to be present for the desired neurological target.
#' Therefore, a compound's ability to permeate relevant biological membranes is
#' critically important to understand early in the drug discovery process.
#' Compounds that appear to be effective for a particular disease in research
#' screening experiments, but appear to be poorly permeable may need to be
#' altered in order improve permeability, and thus the compound's ability to
#' reach the desired target. Identifying permeability problems can help guide
#' chemists towards better molecules.
#'
#' Permeability assays such as PAMPA and Caco-2 have been developed to help
#' measure compounds' permeability (Kansy et al, 1998). These screens are
#' effective at quantifying a compound's permeability, but the assay is
#' expensive labor intensive. Given a sufficient number of compounds that have
#' been screened, we could develop a predictive model for permeability in an
#' attempt to potentially reduce the need for the assay. In this project there
#' were 165 unique compounds; 1107 molecular fingerprints were determined for
#' each. A molecular fingerprint is a binary sequence of numbers that
#' represents the presence or absence of a specific molecular sub-structure.
#' The response is highly skewed, the predictors are sparse (15.5 percent are
#' present), and many predictors are strongly associated.
#'
#'
#' @name permeability
#' @aliases permeability fingerprints
#' @docType data
#' @return \item{permeability}{permeability values for each compound. }
#' \item{fingerprints}{a matrix of binary fingerprint indicator variables.}
#' @source Kansy, M., Senner, F., and Gubernator, K. (1998). Physicochemical
#' High Throughput Screening: Parallel Artificial Membrane Permeation Assay in
#' the Description of Passive Absorption Processes. J. Med. Chem, 41(7),
#' 1007-1010.
#' @keywords datasets
#' @examples
#'
#' data(permeability)
#'
#' hist(permeability)
#'
#' summary(apply(fingerprints, 2, mean))
#'
NULL
#' Cell Body Segmentation
#'
#' Hill, LaPan, Li and Haney (2007) develop models to predict which cells in a
#' high content screen were well segmented. The data consists of 119 imaging
#' measurements on 2019. The original analysis used 1009 for training and 1010
#' as a test set (see the column called \code{Case}).
#'
#' The outcome class is contained in a factor variable called \code{Class} with
#' levels "PS" for poorly segmented and "WS" for well segmented.
#'
#' A pre-processed version of these data can be found in the \pkg{caret}
#' package.
#'
#'
#' @name segmentationOriginal
#' @docType data
#' @return \item{segmentationOriginal}{data frame of cells}
#' @source Hill, LaPan, Li and Haney (2007). Impact of image segmentation on
#' high-content screening data quality for SK-BR-3 cells, \emph{BMC
#' Bioinformatics}, Vol. 8, pg. 340,
#' \url{https://link.springer.com/article/10.1186/1471-2105-8-340}.
#' @keywords datasets
NULL
#' Solubility Data
#'
#' Tetko et al. (2001) and Huuskonen (2000) investigated a set of compounds
#' with corresponding experimental solubility values using complex sets of
#' descriptors. They used linear regression and neural network models to
#' estimate the relationship between chemical structure and solubility. For our
#' analyses, we will use 1267 compounds and a set of more understandable
#' descriptors that fall into one of three groups: 208 binary "fingerprints"
#' that indicate the presence or absence of a particular chemical
#' sub-structure, 16 count descriptors (such as the number of bonds or the
#' number of Bromine atoms) and 4 continuous descriptors (such as molecular
#' weight or surface area).
#'
#'
#' @name solubility
#' @aliases trainX solTestXtrans solTrainY solTestX solTrainX solTrainXtrans solTestY
#' @docType data
#' @return \item{solTrainX}{training set predictors in their natural units. }
#' \item{solTrainXtrans}{training set predictors after transformations for
#' skewness and centering/scaling.} \item{solTrainY}{a vector of log10
#' solubility values for the training set. } \item{solTestX}{test set
#' predictors in their natural units. } \item{solTestXtrans}{test set
#' predictors after the same transformations used on the training set are
#' applied.} \item{solTestY}{a vector of log10 solubility values for the
#' training set. }
#' @source Tetko, I., Tanchuk, V., Kasheva, T., and Villa, A. (2001).
#' Estimation of aqueous solubility of chemical compounds using E-state
#' indices. \emph{Journal of Chemical Information and Computer Sciences},
#' 41(6), 1488-1493.
#'
#' Huuskonen, J. (2000). Estimation of aqueous solubility for a diverse set of
#' organic compounds based on molecular topology. \emph{Journal of Chemical
#' Information and Computer Sciences}, 40(3), 773-777.
#' @keywords datasets
#' @examples
#'
#' data(solubility)
#'
#' library(caret)
#'
#' ### Cross-validation splits used in the book:
#' set.seed(100)
#' indx <- createFolds(solTrainY, returnTrain = TRUE)
#'
#' ### To re-create the transformed version of the data:
#' \dontrun{
#' ## Find the predictors that are not fingerprints
#' contVars <- names(solTrainX)[!grepl("FP", names(solTrainX))]
#' ## Some have zero values, so we need to add one to them so that
#' ## we can use the Box-Cox transformation. Alternatively, we could
#' ## use the Yeo-Johnson transformation without altering the data.
#' contPredTrain <- solTrainX[,contVars] + 1
#' contPredTest <- solTestX[,contVars] + 1
#'
#' pp <- preProcess(contPredTrain, method = "BoxCox")
#' contPredTrain <- predict(pp, contPredTrain)
#' contPredTest <- predict(pp, contPredTest)
#'
#' ## Reassemble the fingerprint data with the transformed values.
#' trainXtrans <- cbind(solTrainX[,grep("FP", names(solTrainX))], contPredTrain)
#' testXtrans <- cbind( solTestX[,grep("FP", names(solTestX))], contPredTest)
#'
#' all.equal(trainXtrans, solTrainXtrans)
#' all.equal(testXtrans, solTestXtrans)
#' }
#'
#'
NULL
#' Two Class Example Data
#'
#' These data contain two predictors measured for 208 samples. Of these, 111
#' samples are labeled as \code{Class1} and the remaining 97 are \code{Class2}.
#'
#'
#' @name twoClassData
#' @aliases twoClassData classes
#' @docType data
#' @return \item{predictors}{data frame of two predictors} \item{classes}{a
#' factor vector of class labeled}
#' @keywords datasets
#' @examples
#'
#' data(twoClassData)
#'
#' library(lattice)
#' xyplot(PredictorB ~ PredictorA,
#' data = predictors,
#' groups = classes,
#' auto.key = TRUE)
#'
#'
NULL
Any scripts or data that you put into this service are public.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.